The Effect of Virtual Reality-Mediated Rehabilitation in Ischemic Stroke Patients
Investigation of the Effect of Virtual Reality-Mediated Rehabilitation on Upper Extremity Functions in Ischemic Stroke Patients
1 other identifier
interventional
32
1 country
1
Brief Summary
The aim of the study was to investigate the effectiveness of virtual reality-mediated upper extremity rehabilitation added to the conventional rehabilitation program on upper extremity, quality of life, range of motion and spasticity in patients with stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFebruary 20, 2024
February 1, 2024
8 months
April 18, 2023
February 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Fugl-Meyer upper extremity scale
This scale is a stroke-specific, performance-based scale and each parameter is scored as 0; unsuccessful, 1; partially successful and 2; completely successful performance. This scale consists of five sections: motor function, balance, sensation, range of motion and pain. The motor function assessment section is scored as 100 points (66 upper extremities and 34 lower extremities), sensation (light touch and position sense) 24 points, balance (6 sitting and 8 standing) 14 points, range of motion 44 points and joint pain 44 points.
Change from Baseline Fugl-Meyer upper extremity scale at 3rd Month After Intervention
Secondary Outcomes (4)
Functional Independence Measure
Change from Baseline Functional Independence Measure at 3rd Month After Intervention
Handgrip Strength
Change from Baseline Handgrip Strength at 3rd Month After Intervention
Modified Ashworth Scale
Change from Baseline Modified Ashworth Scale at 3rd Month After Intervention
Stroke Impact Scale
Change from Baseline Stroke Impact Scale. at 3rd Month After Intervention
Study Arms (2)
Virtual Reality Group
EXPERIMENTALParticipants in both groups will receive a conventional rehabilitation program. Participants in the virtual reality group will receive virtual reality-mediated upper extremity rehabilitation for 3 weeks, 5 sessions per week, each session lasting 30 minutes (450 minutes in total). In the virtual reality intervention, participants will be asked to control the games with hand, wrist and forearm movements in front of a computer screen in front of the SensoRehab® sensor that can detect hand movements through gloves. 3 different games will be intervened for 10 minutes each, totaling 30 minutes per day.
Control Group
ACTIVE COMPARATORParticipants in the control group will be instructed in hand, finger, wrist and forearm therapeutic exercises by a physiotherapist. Participants in both groups will receive a conventional rehabilitation program.
Interventions
In the virtual reality intervention, participants will be asked to control the games with hand, wrist and forearm movements in front of a computer screen in front of the SensoRehab® sensor that can detect hand movements through gloves.
conventional rehabilitation program
Participants in the control group will be instructed in hand, finger, wrist and forearm therapeutic exercises by a physiotherapist.
Eligibility Criteria
You may qualify if:
- to 65 years of age,
- History of Ischemic Stroke
- Accept to participate in the study,
You may not qualify if:
- Presence of known central nervous system or peripheral nervous system disease other than stroke, presence of progressive neurologic deficit,
- Uncontrolled hypertension, diabetes, cardiovascular disease etc.
- Cognitive impairment causing difficulty in executing simple commands
- Epilepsy
- Botulinum toxin application to the upper extremity in the last 6 months
- Change in the medical treatment used for spasticity in the last 6 months
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmet Kıvanç Menekşeoğlu
Istanbul, 34015, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
AHmet Kivanc Menekseoglu, MD
Kanuni Sultan Suleyman Research and Training Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 18, 2023
First Posted
May 22, 2023
Study Start
May 1, 2023
Primary Completion
January 1, 2024
Study Completion
January 1, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share